Exscientia (Exscientia) Debt-to-Equity : 0.08 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Exscientia Debt-to-Equity?

Exscientia's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $3.38 Mil. Exscientia's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $20.95 Mil. Exscientia's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $304.30 Mil. Exscientia's debt to equity for the quarter that ended in Mar. 2024 was 0.08.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Exscientia's Debt-to-Equity or its related term are showing as below:

EXAI' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.04 Max: 0.08
Current: 0.08

During the past 5 years, the highest Debt-to-Equity Ratio of Exscientia was 0.08. The lowest was 0.01. And the median was 0.04.

EXAI's Debt-to-Equity is ranked better than
63.48% of 1068 companies
in the Biotechnology industry
Industry Median: 0.145 vs EXAI: 0.08

Exscientia Debt-to-Equity Historical Data

The historical data trend for Exscientia's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exscientia Debt-to-Equity Chart

Exscientia Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

0.05

0.06

0.01

0.03

0.05

Exscientia Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial												0.04	0.05	0.05	0.05	0.08

Competitive Comparison of Exscientia's Debt-to-Equity

For the Biotechnology subindustry, Exscientia's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exscientia's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exscientia's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Exscientia's Debt-to-Equity falls into.

Exscientia Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Exscientia's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.033	+	20.92)	/	450.286
	=	0.05

Exscientia's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.375	+	20.954)	/	304.302
	=	0.08

Exscientia (NAS:EXAI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Exscientia Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Exscientia's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Exscientia (Exscientia) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exscientia PLC (NAS:EXAI) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

0RK:Germany 0RK:Germany

Address

Oxford Science Park, The Schrodinger Building, Oxford, GBR, OX4 4GE

Website

https://www.exscientia.ai

Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe and efficacious compounds for clinical testing in humans. The company is focused on the discovery and development of small-molecule drug candidates.